Immune-Based Advances in Gastric, Esophageal, and Gastroesophageal Junction Cancers

 
Condividi
 

Manage episode 347696781 series 3128163
Creato da ReachMD, autore scoperto da Player FM e dalla nostra community - Il copyright è detenuto dall'editore, non da Player FM, e l'audio viene riprodotto direttamente dal suo server. Clicca sul pulsante Iscriviti per rimanere aggiornato su Player FM, o incolla l'URL del feed in un altra app per i podcast.
CME credits: 0.50
Valid until: 15-11-2023
Claim your CME credit at https://reachmd.com/programs/cme/immune-based-advances-in-gastric-esophageal-and-gastroesophageal-junction-cancers/14481/
Recent immunotherapy approvals for gastric, esophageal, and gastroesophageal junction cancers have transformed the treatment landscape. Listen in as Drs. Eric Van Cutsem, Elizabeth Smyth, and Sunnie Kim discuss the most recent data for immunotherapy in these settings. What impact will these advances have on your clinical practice?

993 episodi